Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on June 5, 2025
Ear Nose and Throat Clinic of Coffee County’s Dr. George Livermore Shares Insights as Sinus Pain Relief Expert in HelloNation Magazine
GlobeNewswire
·
June 5, 2025
DOUGLAS, Ga., June 05, 2025 (GLOBE NEWSWIRE) -- What should individuals do when seasonal congestion becomes more than just an occasional nuisance? According to Dr. George Livermore of the Ear Nose and Throat Clinic of Coffee County, recognizing the signs …
DIOSynVax Presents Its Technology at the Invitation-Only Next Venture Capital Unit (VCU) Health Tech Showcase at the London Stock Exchange
GlobeNewswire
·
June 5, 2025
CAMBRIDGE, United Kingdom and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing safe, innovative, broadly protective vaccines presented its unique broad-based vaccine technology at …
Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment
GlobeNewswire
·
June 5, 2025
HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal disease Osteoporosis is a common progressive bone disease among adults over 50 years of age that causes bones to weaken, leading to fractures …
FOREWARN to Provide Identity Verification Services to Mid Jersey Association of REALTORS® to Promote Agent Safety
GlobeNewswire
·
June 5, 2025
BOCA RATON, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Mid Jersey Association of REALTORS® (“MJAR”) …
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire
·
June 5, 2025
CUPERTINO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 5, 2025
BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards …
Core Molding Technologies to Present and Host 1x1 Meetings at the 15th Annual East Coast IDEAS Investor Conference on June 11, 2025
GlobeNewswire
·
June 5, 2025
COLUMBUS, Ohio, June 05, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …
Annovis to Host Webinar and Live Q&A on June 24, 2025
GlobeNewswire
·
June 5, 2025
MALVERN, Pa., June 05, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s …
SeekOut Appoints Veteran B2B Executive Bala Vishwanath as Chief Marketing Officer to Lead Talent Acquisition's Agentic AI Revolution
GlobeNewswire
·
June 5, 2025
SEATTLE, June 05, 2025 (GLOBE NEWSWIRE) -- SeekOut, the Agentic AI talent acquisition platform, today announced Bala Vishwanath as Chief Marketing Officer, positioning the company to lead recruiting's most fundamental transformation since the dawn of the …
Magnite Integrates Anoki ContextIQ Platform and AI Copilot to Bring Scene Level Targeting to CTV
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI), the largest independent sell-side advertising company, today announced the integration of Anoki ContextIQ, the industry-leading multimodal AI platform for contextual video intelligence at …
authID Integrates with Ping Identity’s DaVinci to Provide Passwordless, Privacy-Preserving Biometrics
GlobeNewswire
·
June 5, 2025
Denver, Colorado, June 05, 2025 (GLOBE NEWSWIRE) -- authID, a leading provider of identity proofing and biometric authentication, today announced a new integration with Ping Identity, a leader in securing digital identities for the world's largest …
Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107)
GlobeNewswire
·
June 5, 2025
Access the on-demand webcast here HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat …
ZenaTech Launches Drone as a Service (DaaS) for US Defense and Government Agencies with New Partnerships
GlobeNewswire
·
June 5, 2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and …
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
GlobeNewswire
·
June 5, 2025
BOTHELL, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS) …
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
GlobeNewswire
·
June 5, 2025
NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
IMUNON to Present at the Zacks SCR Life Sciences Virtual Investor Forum on June 12th
GlobeNewswire
·
June 5, 2025
LAWRENCEVILLE, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that Stacy Lindborg, Ph.D., President and Chief Executive Officer of …
Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
GlobeNewswire
·
June 5, 2025
EMA Orphan Drug Designation (ODD) builds on U.S. Food …
ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
GlobeNewswire
·
June 5, 2025
VeonGen advances two proprietary, first-in-class gene therapies in the clinic, enabled by its novel vgRNA REVeRT and vgAAV technology platforms Lead program VG801 receives FDA Rare Pediatric Disease Designation and is progressing in a first-in-human Phase …
AgEagle Aerial Systems Provides Technology to Enhance European Security
GlobeNewswire
·
June 5, 2025
Government of Sweden orders eBee TAC Public Safety systems WICHITA, Kan., June 05, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is pleased to announce orders for …
Polpharma Group Supports Urgent EU Action to Safeguard Access to Medicines and Strengthen European Pharmaceutical Sovereignty
GlobeNewswire
·
June 5, 2025
AMSTERDAM, June 05, 2025 (GLOBE NEWSWIRE) -- Polpharma Group, a leading European pharmaceutical manufacturer, has joined fellow members of Medicines for Europe in signing an open letter addressed to the Prime Ministers and Ministers of Health of all 27 EU …